Literature DB >> 18830265

Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement.

G Gaipa, C Bugarin, D Longoni, S Cesana, C Molteni, A Faini, F Timeus, M Zecca, A Biondi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18830265     DOI： 10.1038/leu.2008.265

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies.

Authors:  Abhisek Mitra; Jeremy A Ross; Georgialina Rodriguez; Zsuzsanna S Nagy; Harry L Wilson; Robert A Kirken
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

Review 2.  Diagnostic Tools for Inborn Errors of Human Immunity (Primary Immunodeficiencies and Immune Dysregulatory Diseases).

Authors:  Annely M Richardson; Ann M Moyer; Linda Hasadsri; Roshini S Abraham
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-22       Impact factor: 4.806

3.  Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency.

Authors:  Francesco Saettini; Cecilia Poli; Jaime Vengoechea; Sonia Bonanomi; Julio C Orellana; Grazia Fazio; Fred H Rodriguez; Loreani P Noguera; Claire Booth; Valentina Jarur-Chamy; Marissa Shams; Maria Iascone; Maja Vukic; Serena Gasperini; Manuel Quadri; Amairelys Barroeta Seijas; Elizabeth Rivers; Mario Mauri; Raffaele Badolato; Gianni Cazzaniga; Cristina Bugarin; Giuseppe Gaipa; Wilma G M Kroes; Daniele Moratto; Monique M van Oostaijen-Ten Dam; Frank Baas; Silvère van der Maarel; Rocco Piazza; Zeynep H Coban-Akdemir; James R Lupski; Bo Yuan; Ivan K Chinn; Lucia Daxinger; Andrea Biondi
Journal:  Blood       Date:  2021-01-28       Impact factor: 22.113

4.  Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia.

Authors:  Jinyong Wang; Yangang Liu; Zeyang Li; Juan Du; Myung-Jeom Ryu; Philip R Taylor; Mark D Fleming; Ken H Young; Henry Pitot; Jing Zhang
Journal:  Blood       Date:  2010-10-04       Impact factor: 22.113

5.  GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia.

Authors:  Eric Padron; Jeffrey S Painter; Sateesh Kunigal; Adam W Mailloux; Kathy McGraw; Jessica M McDaniel; Eunhee Kim; Christopher Bebbington; Mark Baer; Geoffrey Yarranton; Jeffrey Lancet; Rami S Komrokji; Omar Abdel-Wahab; Alan F List; Pearlie K Epling-Burnette
Journal:  Blood       Date:  2013-04-30       Impact factor: 25.476

6.  Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia.

Authors:  D Hasegawa; C Bugarin; M Giordan; S Bresolin; D Longoni; C Micalizzi; U Ramenghi; A Bertaina; G Basso; F Locatelli; A Biondi; G Te Kronnie; G Gaipa
Journal:  Blood Cancer J       Date:  2013-11-15       Impact factor: 11.037

7.  Restoration of MYC-repressed targets mediates the negative effects of GM-CSF on RUNX1-ETO leukemogenicity.

Authors:  S Weng; S Matsuura; C T Mowery; S A Stoner; K Lam; D Ran; A G Davis; M-C Lo; D-E Zhang
Journal:  Leukemia       Date:  2016-06-15       Impact factor: 11.528
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.